DigiNepal
Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospital Hong Kong and Hong Kong Sanatorium & Hospital would launch the trials using histotripsy, a…